Patrick G. Swann

3.2k total citations · 1 hit paper
26 papers, 2.5k citations indexed

About

Patrick G. Swann is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging and Immunology. According to data from OpenAlex, Patrick G. Swann has authored 26 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 8 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Immunology. Recurrent topics in Patrick G. Swann's work include Viral Infectious Diseases and Gene Expression in Insects (8 papers), Protein purification and stability (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Patrick G. Swann is often cited by papers focused on Viral Infectious Diseases and Gene Expression in Insects (8 papers), Protein purification and stability (8 papers) and Monoclonal and Polyclonal Antibodies Research (8 papers). Patrick G. Swann collaborates with scholars based in United States, United Kingdom and Germany. Patrick G. Swann's co-authors include Mark J. Rose, Jeffrey Sailstad, Anthony J. DeStefano, Jerome P. Skelly, Russell Weiner, Vinod P. Shah, C.T. Viswanathan, Surendra K. Bansal, Brian Booth and Steven Kozlowski and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Advanced Drug Delivery Reviews.

In The Last Decade

Patrick G. Swann

26 papers receiving 2.3k citations

Hit Papers

Quantitative Bioanalytical Methods Validation and Impleme... 2007 2026 2013 2019 2007 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays
    2007 667 citations C.T. Viswanathan, Surendra K. Bansal et al. Pharmaceutical Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Patrick G. Swann United States 18 1.4k 658 515 250 235 26 2.5k
Mark E. Arnold United States 30 947 0.7× 674 1.0× 269 0.5× 247 1.0× 514 2.2× 100 2.5k
Russell Weiner United States 21 1.3k 1.0× 1.8k 2.7× 556 1.1× 150 0.6× 245 1.0× 40 3.7k
Anne‐Françoise Aubry United States 25 814 0.6× 349 0.5× 267 0.5× 200 0.8× 530 2.3× 70 1.8k
Marian Kelley United States 14 774 0.6× 910 1.4× 555 1.1× 99 0.4× 67 0.3× 23 1.6k
Yan Cao China 34 2.1k 1.5× 370 0.6× 179 0.3× 160 0.6× 293 1.2× 172 3.5k
Francis L. S. Tse Japan 28 721 0.5× 585 0.9× 99 0.2× 257 1.0× 486 2.1× 110 2.7k
Bradley L. Ackermann United States 28 1.3k 1.0× 250 0.4× 134 0.3× 200 0.8× 803 3.4× 63 2.5k
Iain Gardner United Kingdom 28 987 0.7× 239 0.4× 315 0.6× 130 0.5× 198 0.8× 94 2.9k
Surendra K. Bansal United States 19 750 0.6× 478 0.7× 87 0.2× 98 0.4× 297 1.3× 45 2.1k
Norihiro Kobayashi Japan 24 1.3k 1.0× 178 0.3× 826 1.6× 183 0.7× 120 0.5× 121 2.2k

Countries citing papers authored by Patrick G. Swann

Since Specialization
Citations

This map shows the geographic impact of Patrick G. Swann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick G. Swann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick G. Swann more than expected).

Fields of papers citing papers by Patrick G. Swann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Patrick G. Swann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick G. Swann. The network helps show where Patrick G. Swann may publish in the future.

Co-authorship network of co-authors of Patrick G. Swann

This figure shows the co-authorship network connecting the top 25 collaborators of Patrick G. Swann. A scholar is included among the top collaborators of Patrick G. Swann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Patrick G. Swann. Patrick G. Swann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rogers, Richard S., Douglas D. Richardson, Jason C. Rouse, et al.. (2017). A View on the Importance of “Multi-Attribute Method” for Measuring Purity of Biopharmaceuticals and Improving Overall Control Strategy. The AAPS Journal. 20(1). 7–7. 112 indexed citations
2.
Li, Yinyin, Michael Monine, Yü Huang, et al.. (2016). Quantitation and pharmacokinetic modeling of therapeutic antibody quality attributes in human studies. mAbs. 8(6). 1079–1087. 19 indexed citations
3.
Lyubarskaya, Yelena, Kazumi Kobayashi, & Patrick G. Swann. (2015). Application of mass spectrometry to facilitate advanced process controls of biopharmaceutical manufacture. Zenodo (CERN European Organization for Nuclear Research). 3(4). 313–321. 11 indexed citations
4.
Ma, Stacey, et al.. (2011). Glycosylation of Therapeutic Proteins Current Understanding of Structure-Function Relationships. 4 indexed citations
5.
Carpenter, John F., Theodore W. Randolph, Wim Jiskoot, et al.. (2008). Overlooking Subvisible Particles in Therapeutic Protein Products: Gaps That May Compromise Product Quality. Journal of Pharmaceutical Sciences. 98(4). 1201–1205. 440 indexed citations
6.
Swann, Patrick G., Máté Tolnay, Subramanian Muthukkumar, et al.. (2008). Considerations for the development of therapeutic monoclonal antibodies. Current Opinion in Immunology. 20(4). 493–499. 49 indexed citations
7.
Viswanathan, C.T., Surendra K. Bansal, Brian Booth, et al.. (2007). Quantitative Bioanalytical Methods Validation and Implementation: Best Practices for Chromatographic and Ligand Binding Assays. Pharmaceutical Research. 24(10). 1962–1973. 667 indexed citations breakdown →
8.
Kozlowski, Steven & Patrick G. Swann. (2006). Current and future issues in the manufacturing and development of monoclonal antibodies. Advanced Drug Delivery Reviews. 58(5-6). 707–722. 121 indexed citations
9.
Brorson, Kurt, Yuan Xu, Patrick G. Swann, et al.. (2002). Evaluation of a Quantitative Product-enhanced Reverse Transcriptase Assay to Monitor Retrovirus in mAb Cell-culture. Biologicals. 30(1). 15–26. 25 indexed citations
10.
Brorson, Kurt, Elizabeth Hamilton, Patrick G. Swann, et al.. (2002). Impact of cell culture process changes on endogenous retrovirus expression. Biotechnology and Bioengineering. 80(3). 257–267. 23 indexed citations
11.
Brorson, Kurt, et al.. (2001). Use of a Quantitative Product-Enhanced Reverse Transcriptase Assay to Monitor Retrovirus Levels in mAb Cell-Culture and Downstream Processing. Biotechnology Progress. 17(1). 188–196. 24 indexed citations
12.
Swann, Patrick G., Sandra Odom, Yongjie Zhou, et al.. (1999). Requirement for a Negative Charge at Threonine 60 of the FcRγ for Complete Activation of Syk. Journal of Biological Chemistry. 274(33). 23068–23077. 17 indexed citations
13.
14.
15.
Swann, Patrick G., Carole A. Parent, Martine Croset, et al.. (1990). Enrichment of platelet phospholipids with eicosapentaenoic acid and docosahexaenoic acid inhibits thromboxane A2/prostaglandin H2 receptor binding and function.. Journal of Biological Chemistry. 265(35). 21692–21697. 61 indexed citations
16.
Swann, Patrick G., Duane L. Venton, & Guy C. Le Breton. (1989). Eicosapentaenoic acid and docosahexaenoic acid are antagonists at the thromboxane A2/prostaglandin H2 receptor in human platelets. FEBS Letters. 243(2). 244–246. 70 indexed citations
17.
Marczynski, T.J., et al.. (1988). Perinatal upregulation of benzodiazepine receptor ontogenesis: “Fearless” and more efficient goal-directed behavior of adult rat progenies. Neurotoxicology and Teratology. 10(2). 101–111. 26 indexed citations
18.
Swann, Patrick G., et al.. (1952). A Case of Palpable Parathyroid Tumour. BMJ. 2(4795). 1185–1186. 5 indexed citations
19.
Swann, Patrick G., et al.. (1952). M. & B. 1863, a Homologue of Hexamethonium, in Treatment of Hypertension. BMJ. 1(4752). 254–258. 6 indexed citations
20.
Swann, Patrick G., et al.. (1951). Methonium Compounds in the Treatment of Hypertension. BMJ. 1(4710). 778–784. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mark E. Arnold Breakdown of academic impact, for papers by Russell Weiner Breakdown of academic impact, for papers by Anne‐Françoise Aubry Breakdown of academic impact, for papers by Marian Kelley Breakdown of academic impact, for papers by Yan Cao Breakdown of academic impact, for papers by Francis L. S. Tse Breakdown of academic impact, for papers by Bradley L. Ackermann Breakdown of academic impact, for papers by Iain Gardner Breakdown of academic impact, for papers by Surendra K. Bansal Breakdown of academic impact, for papers by Norihiro Kobayashi
Rankless by CCL
2026